Marqibo ( vincristine sulfate liposome injection) has been approved by the U.S. Food and Drug Administration to treat adults with a rare type of leukemia called Philadelphia chromosome negative ( Ph -) acute lymphoblastic leukemia (ALL).

Since targeted therapies known as tyrosine kinase inhibitors (TKI) have been in use, the outlook for people diagnosed with chronic myeloid leukemia has improved dramatically. Unfortunately, this trend isn't true for all patients.

Roughly one percent of the 4 million children born in the U.S. every year are conceived through in vitro fertilization ( IVF ). According to the CDC, just over 47,000 IVF children were born in 2010.

Our cells are constantly changing, just like we are. These include mutations that occur over a lifetime, all of which are part of normal aging. Add in a few more mutations, though, and you've got cancer.

Benzene is a chemical that's used in a number of industrial processes. People who are exposed to this chemical in the workplace may have increased cancer risks.

The course of chronic myeloid leukemia (CML) has changed substantially thanks to the use of a class of drugs called tyrosine kinase inhibitors (TKIs). How these drugs are being used is changing too.

Leukemia is a disease of the blood cells. Acute myeloid leukemia (AML) is seen as an explosion of cancer cells in the bone marrow.

A lot of medical research may not prove beneficial to patients right away, but all research advances the disease knowledge base. Such is the case with a new study relating to multiple myeloma , a rare blood cancer.

The link between cancer and the body's metabolism is a scientific focus that is bearing more fruit. An " oncometabolite " is cancer-causing metabolite that's involved in the development and progression of cancer.

Multiple myeloma is a cancer similar to leukemia, where immune system cells in the blood begin to multiply out of control.